Is the pathogenesis of ischemic heart disease different between men and women? Gerald M. Pohost Editor’s Commentary Pages: 241 - 242
Surgical, medical, and percutaneous therapies for patients with multivessel coronary artery disease Murtuza J. AliRavin Davidoff OriginalPaper Pages: 247 - 254
Revascularization for patients with severe coronary artery disease and left ventricular dysfunction Tapas GhoseRandall C. Thompson OriginalPaper Pages: 255 - 260
Primary prevention for patients with intermediate framingham Risk Scores Jason B. ThompsonJuan J. RiveraPeter Danyi OriginalPaper Pages: 261 - 266
Clopidogrel treatment surrounding percutaneous coronary intervention: When should it be started and stopped? Alanna CoolongLaura Mauri OriginalPaper Pages: 267 - 271
Treatment options for refractory angina in patients who are not candidates for revascularization C. Richard Conti OriginalPaper Pages: 272 - 276
Current status of risk stratification methods in acute coronary syndromes Raphael SeeJames A. de Lemos OriginalPaper Pages: 282 - 288
Special issues when caring for the older person with acute coronary syndromes Rahman ShahJoAnne Micale Foody OriginalPaper Pages: 289 - 295
Acute coronary syndromes in patients with renal disease: What are the issues? Carmelo J. PanettaCharles A. HerzogTimothy D. Henry OriginalPaper Pages: 296 - 300
Antiplatelet resistance with aspirin and clopidogrel: Is it real and does it matter? Wai-Hong Chen OriginalPaper Pages: 301 - 306